Trial Profile
The pharmacokinetics, safety, tolerability and the effect on EPO levels after single oral doses of molidustat in healthy male volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Apr 2018
Price :
$35
*
At a glance
- Drugs Molidustat (Primary)
- Indications Anaemia
- Focus First in man; Pharmacokinetics; Proof of concept
- 13 Apr 2018 New trial record
- 25 Mar 2018 Results published in the British Journal of Clinical Pharmacology